Phase II window of irinotecan plus carboplatin in newly diagnosed patients with rhandomyosarcoma: Results of Memorial Sloan-Kettering Cancer Center (MSKCC) Protocol IRB 03-099 Meeting Abstract


Authors: Wexler, L. H.; Wolden, S. L.; Abramson, S. J.; Price, A.; Karimi, S.; La Quaglia, M. P.; Chou, A. J.; Merola, P. R.; Meyers, P. A.
Abstract Title: Phase II window of irinotecan plus carboplatin in newly diagnosed patients with rhandomyosarcoma: Results of Memorial Sloan-Kettering Cancer Center (MSKCC) Protocol IRB 03-099
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 686s
Language: English
ACCESSION: WOS:000208852005462
DOI: 10.1200/jco.2010.28.15_suppl.9533
PROVIDER: wos
Notes: Meeting Abstract: 9533 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Suzanne L Wolden
    560 Wolden
  2. Leonard H Wexler
    192 Wexler
  3. Alexander Ja-Ho Chou
    58 Chou
  4. Sasan Karimi
    115 Karimi
  5. Paul Meyers
    311 Meyers
  6. Pamela Merola
    11 Merola